IKZF3: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''IKZF3''' ( | |||
{{Infobox gene | |||
| name = IKZF3 | |||
| symbol = IKZF3 | |||
| HGNCid = 6070 | |||
| OMIM = 606221 | |||
| EntrezGene = 22806 | |||
| RefSeq = NM_012481 | |||
| UniProt = Q9UKT9 | |||
}} | |||
'''IKZF3''' (Ikaros Family Zinc Finger 3) is a protein-coding gene that plays a crucial role in the regulation of [[lymphocyte]] development. It is a member of the [[Ikaros family]] of transcription factors, which are essential for the normal development of the [[immune system]]. | |||
== Function == | == Function == | ||
IKZF3 encodes a transcription factor that is involved in the regulation of [[gene expression]] during the development of [[B cells]] and [[T cells]]. It is known to interact with other members of the Ikaros family, such as [[IKZF1]] and [[IKZF2]], to modulate the transcriptional activity of target genes. The protein contains multiple [[zinc finger]] domains, which facilitate its binding to [[DNA]] and its role in chromatin remodeling. | |||
The | |||
== Clinical | == Clinical Significance == | ||
Mutations | Mutations or dysregulation of the IKZF3 gene have been associated with various [[immune disorders]] and [[hematological malignancies]]. For instance, alterations in IKZF3 expression have been observed in certain types of [[leukemia]] and [[lymphoma]]. Additionally, IKZF3 is a target for therapeutic intervention in diseases such as [[multiple myeloma]], where it is involved in the survival and proliferation of malignant cells. | ||
== | == Interactions == | ||
IKZF3 interacts with several other proteins and transcription factors to exert its effects on gene expression. It forms complexes with other Ikaros family members and is involved in the regulation of [[chromatin structure]]. These interactions are critical for its function in [[lymphocyte]] development and immune response. | |||
[[ | == Research and Therapeutic Implications == | ||
Research into IKZF3 has provided insights into its role in [[immune regulation]] and its potential as a therapeutic target. Inhibitors targeting IKZF3 and related pathways are being explored for the treatment of [[autoimmune diseases]] and [[cancers]]. Understanding the precise mechanisms by which IKZF3 regulates gene expression and immune cell function is an ongoing area of study. | |||
== See | == See Also == | ||
* [[Ikaros family]] | * [[Ikaros family]] | ||
* [[Transcription factor]] | * [[Transcription factor]] | ||
* [[ | * [[Zinc finger]] | ||
* [[ | * [[Lymphocyte]] | ||
== References == | == References == | ||
<references /> | <references/> | ||
== External Links == | |||
* [https://www.ncbi.nlm.nih.gov/gene/22806 IKZF3 Gene - NCBI] | |||
* [https://www.uniprot.org/uniprot/Q9UKT9 IKZF3 Protein - UniProt] | |||
[[Category:Genes | [[Category:Genes on human chromosome 17]] | ||
[[Category:Transcription factors]] | [[Category:Transcription factors]] | ||
[[Category: | [[Category:Zinc finger proteins]] | ||
[[Category: | [[Category:Immune system]] | ||
Latest revision as of 20:29, 30 December 2024
| Symbol | IKZF3 |
|---|---|
| HGNC ID | 6070 |
| Alternative symbols | – |
| Entrez Gene | 22806 |
| OMIM | 606221 |
| RefSeq | NM_012481 |
| UniProt | Q9UKT9 |
| Chromosome | – |
| Locus supplementary data | – |
IKZF3 (Ikaros Family Zinc Finger 3) is a protein-coding gene that plays a crucial role in the regulation of lymphocyte development. It is a member of the Ikaros family of transcription factors, which are essential for the normal development of the immune system.
Function[edit]
IKZF3 encodes a transcription factor that is involved in the regulation of gene expression during the development of B cells and T cells. It is known to interact with other members of the Ikaros family, such as IKZF1 and IKZF2, to modulate the transcriptional activity of target genes. The protein contains multiple zinc finger domains, which facilitate its binding to DNA and its role in chromatin remodeling.
Clinical Significance[edit]
Mutations or dysregulation of the IKZF3 gene have been associated with various immune disorders and hematological malignancies. For instance, alterations in IKZF3 expression have been observed in certain types of leukemia and lymphoma. Additionally, IKZF3 is a target for therapeutic intervention in diseases such as multiple myeloma, where it is involved in the survival and proliferation of malignant cells.
Interactions[edit]
IKZF3 interacts with several other proteins and transcription factors to exert its effects on gene expression. It forms complexes with other Ikaros family members and is involved in the regulation of chromatin structure. These interactions are critical for its function in lymphocyte development and immune response.
Research and Therapeutic Implications[edit]
Research into IKZF3 has provided insights into its role in immune regulation and its potential as a therapeutic target. Inhibitors targeting IKZF3 and related pathways are being explored for the treatment of autoimmune diseases and cancers. Understanding the precise mechanisms by which IKZF3 regulates gene expression and immune cell function is an ongoing area of study.
See Also[edit]
References[edit]
<references/>
